Premium
Redo of percutaneous renal denervation in a patient with recurrent resistant hypertension after primary treatment success
Author(s) -
Lambert T.,
Nahler A.,
Leisch F.
Publication year - 2013
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.24753
Subject(s) - medicine , blood pressure , percutaneous , denervation , resistant hypertension , regimen , secondary hypertension , surgery , cardiology
A 79‐year‐old patient was treated with percutaneous renal denervation (RDN) due to resistant arterial hypertension in the summer of 2010. After primary treatment success with a decrease of blood pressure from 170/100 to 130/80 mm Hg 6 months postablation, the blood pressure rose again at 12 months despite maintenance of the pharmacologic regimen and the decision was made to perform a second RDN procedure. Three months following the second RDN procedure, blood pressure was lowered to 130/77 mm Hg. © 2012 Wiley Periodicals, Inc.